Michelle Poon

1.3k total citations
38 papers, 236 citations indexed

About

Michelle Poon is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Michelle Poon has authored 38 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 15 papers in Hematology. Recurrent topics in Michelle Poon's work include Lymphoma Diagnosis and Treatment (15 papers), Acute Lymphoblastic Leukemia research (11 papers) and CAR-T cell therapy research (10 papers). Michelle Poon is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Acute Lymphoblastic Leukemia research (11 papers) and CAR-T cell therapy research (10 papers). Michelle Poon collaborates with scholars based in Singapore, United States and South Korea. Michelle Poon's co-authors include Partow Kebriaei, Liang Piu Koh, Yen Lin Chee, Richard E. Champlin, Celina Ledesma, Julian W. Tang, Jonathan E. Brammer, Chitra Hosing, Richard T. Maziarz and Francesca Lim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michelle Poon

32 papers receiving 232 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michelle Poon Singapore 10 103 101 74 64 45 38 236
Jeremy Ramdial United States 10 129 1.3× 121 1.2× 86 1.2× 30 0.5× 63 1.4× 62 310
T Iseki Japan 11 78 0.8× 195 1.9× 62 0.8× 50 0.8× 67 1.5× 20 320
Ayumi Numata Japan 11 97 0.9× 147 1.5× 78 1.1× 39 0.6× 76 1.7× 38 310
Inna Timofeeva Italy 10 126 1.2× 126 1.2× 65 0.9× 29 0.5× 81 1.8× 17 273
Masanobu Kasai Japan 9 106 1.0× 177 1.8× 88 1.2× 105 1.6× 63 1.4× 23 340
Bruce Greig United States 7 82 0.8× 151 1.5× 104 1.4× 97 1.5× 60 1.3× 10 319
Anthony Sabulski United States 8 124 1.2× 56 0.6× 37 0.5× 33 0.5× 119 2.6× 37 272
Elena V. Babenko Russia 9 106 1.0× 195 1.9× 54 0.7× 56 0.9× 130 2.9× 45 324
Frank Rothmann Germany 7 53 0.5× 98 1.0× 68 0.9× 27 0.4× 62 1.4× 13 219
Dipenkumar Modi United States 10 129 1.3× 132 1.3× 64 0.9× 37 0.6× 65 1.4× 61 272

Countries citing papers authored by Michelle Poon

Since Specialization
Citations

This map shows the geographic impact of Michelle Poon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Poon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Poon more than expected).

Fields of papers citing papers by Michelle Poon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Poon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Poon. The network helps show where Michelle Poon may publish in the future.

Co-authorship network of co-authors of Michelle Poon

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Poon. A scholar is included among the top collaborators of Michelle Poon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Poon. Michelle Poon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Xiao, Esther Hian Li Chan, Sanjay De Mel, et al.. (2024). Evaluating the Comprehensive Geriatric Assessment Model As an Assessment Tool to Predict Chemotoxicity in Elderly Patients with Lymphoma. Blood. 144(Supplement 1). 388–388.
2.
Chee, Yen Lin, Esther Hian Li Chan, Michelle Poon, et al.. (2024). Characteristics and Outcomes of Acute Myeloid Leukemia in Ethnically Diverse Asians in Singapore. Blood. 144(Supplement 1). 7899–7899.
3.
Chan, Jason Yongsheng, Nagavalli Somasundaram, Nicholas F. Grigoropoulos, et al.. (2023). Evolving therapeutic landscape of diffuse large B-cell lymphoma: challenges and aspirations. Discover Oncology. 14(1). 132–132. 9 indexed citations
4.
Poon, Michelle, Jan Walewski, Isidro Jarque, et al.. (2023). ODRONEXTAMAB IN PATIENTS WITH RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL): RESULTS FROM A PRESPECIFIED ANALYSIS OF THE PIVOTAL PHASE II STUDY ELM‐2. Hematological Oncology. 41(S2). 141–142. 5 indexed citations
5.
Tan, Nicole, Ruklanthi de Alwis, Kamini Kunasegaran, et al.. (2022). Enhanced BNT162b2 vaccine-induced cellular immunity in anti-CD19 CAR T cell–treated patients. Blood. 140(2). 156–160. 12 indexed citations
6.
Kim, Won-Seog, Tae Min Kim, Seok‐Goo Cho, et al.. (2022). Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2. Blood. 140(Supplement 1). 1070–1071. 24 indexed citations
7.
8.
Yoon, Sang Eun, Seung Ju Kim, Dok Hyun Yoon, et al.. (2020). 257O Intercontinental cooperative non-Hodgkin T-cell lymphoma prospective registry study in Asia: ICT study. Annals of Oncology. 31. S1343–S1344. 1 indexed citations
9.
10.
Abid, Muhammad Bilal, et al.. (2017). Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from Singapore. Bone Marrow Transplantation. 52(7). 1044–1046. 10 indexed citations
11.
Diong, Colin Phipps, S. Gopalakrishnan, Aloysius Ho, et al.. (2016). An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication. Bone Marrow Transplantation. 52(3). 363–371. 3 indexed citations
12.
Brammer, Jonathan E., Rima M. Saliba, Jeffrey L. Jorgensen, et al.. (2016). Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomes. Bone Marrow Transplantation. 52(1). 20–27. 34 indexed citations
13.
Hobbs, Gabriela, Amir Hamdi, Patrick Hilden, et al.. (2015). Comparison of outcomes at two institutions of patients with ALL receiving ex vivo T-cell-depleted or unmodified allografts. Bone Marrow Transplantation. 50(4). 493–498. 28 indexed citations
14.
Kebriaei, Partow & Michelle Poon. (2015). Future of Therapy in Acute Lymphoblastic Leukemia (ALL)—Potential Role of Immune-Based Therapies. Current Hematologic Malignancy Reports. 10(2). 76–85. 7 indexed citations
15.
Poon, Michelle, Patricia S. Fox, Barry I. Samuels, et al.. (2014). Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis. Leukemia & lymphoma. 56(3). 711–715. 9 indexed citations
16.
Ma, Liyuan, Siguo Hao, Colin Phipps Diong, et al.. (2014). WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients. Annals of Hematology. 94(5). 761–769. 1 indexed citations
17.
18.
Poon, Michelle, Julian W. Tang, & Yen Lin Chee. (2011). Case report: Cytomegalovirus‐induced thrombosis in an immunocompetent patient. Journal of Medical Virology. 84(1). 116–118. 11 indexed citations
19.
Lee, Lai Heng, Ponnudurai Kuperan, Lip Kun Tan, et al.. (2011). Hereditary thrombophilia in an unselected cohort of venous thrombosis patients in Singapore. Journal of Clinical Pathology. 64(9). 814–817. 10 indexed citations
20.
Koh, Liang Piu, Lea Choung Wong, Siok‐Bian Ng, Michelle Poon, & Jeffrey Low. (2009). Primary cutaneous anaplastic large cell lymphoma of the vulva: a typical cutaneous lesion with an ‘atypical’ presenting site. International Journal of Hematology. 90(3). 388–391. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeremy Ramdial Breakdown of academic impact, for papers by T Iseki Breakdown of academic impact, for papers by Ayumi Numata Breakdown of academic impact, for papers by Inna Timofeeva Breakdown of academic impact, for papers by Masanobu Kasai Breakdown of academic impact, for papers by Bruce Greig Breakdown of academic impact, for papers by Anthony Sabulski Breakdown of academic impact, for papers by Elena V. Babenko Breakdown of academic impact, for papers by Frank Rothmann Breakdown of academic impact, for papers by Dipenkumar Modi
Rankless by CCL
2026